Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes.

Christopher W RoweBrendan WatkinsKarina BrownMatthew DelbridgeJordan AddleyAndrew WoodsKatie Wynne

Published in: Diabetic medicine : a journal of the British Diabetic Association (2020)

The Pregnancy-IVI algorithm is safe and effective when used following betamethasone in type 1 diabetes in pregnancy. Further study of women with type 2 diabetes is required.

Keyphrases

type diabetes
preterm birth
pregnancy outcomes
glycemic control
pregnant women
cardiovascular disease
randomized controlled trial
insulin resistance
machine learning
high dose
deep learning
metabolic syndrome
skeletal muscle
neural network